- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Top 50 global pharmaceutical and biotech companies by R&D intensity in 2017/2018
Top 50 global pharmaceutical and biotech companies by R&D intensity in 2017/2018
World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2017/2018*
by Matej Mikulic,
last edited
Jan 7, 2019
This statistic represents the worlds's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2017/2018. In that year, Tanvex Biopharma from Taiwan had the highest R&D intensity of over 800,000 percent. The R&D intensity is calculated from a company's R&D spending divided by the company's sales.
World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2017/2018*
Loading statistic...
Expand statistic
| R&D intensity | |
|---|---|
| Tanvex Biopharma | 821,643.6% |
| Obseva | 342,928.1% |
| Verona Pharma | 103,118.1% |
| Nantkwest | 88,322.1% |
| Endocyte | 82,756.3% |
| Regulus Therapeutics | 70,840.3% |
| TG Therapeutics | 67,287.9% |
| Bellicum Pharma | 35,393.7% |
| Intra-Cellular | 32,305.2% |
| Revance Therapeutics | 30,672.3% |
| Selecta Biosciences | 20,269.7% |
| Dynavax Technologies | 19,774% |
| Alder Biopharmaceuticals | 15,514.7% |
| Flexion Therapeutics | 14,431.3% |
| Clearside Biomedical | 14,118.3% |
| Vtv Therapeutics | 13,522% |
| Coherus Biosciences | 10,336.2% |
| Northwest Biotherapeutics | 9,874.7% |
| Ultragenyx Pharmaceutical | 8,749.8% |
| Isotechnika Pharma | 8,078.1% |
| Karyopharm Therapeutics | 6,583.7% |
| Ascendis Pharma | 6,463.3% |
| Idera Pharmaceuticals | 5,515.6% |
| Stemline Therapeutics | 5,493.5% |
| Cara Therapeutics | 5,246.2% |
| Tigenix | 5,031.6% |
| Syros Pharmaceuticals | 3,705.3% |
| Otonomy | 3,454.8% |
| Arcus Biosciences | 3,241.7% |
| Mesoblast | 2,877.5% |
| Unity Biotechnology | 2,704.3% |
| Immunomedics | 2,384.6% |
| Aclaris Therapeutics | 2,364.2% |
| Syndax Pharma | 2,286.6% |
| Dermira | 2,199.3% |
| Wave Life Sciences | 2,141.2% |
| Adverum Biotechnologies | 2,054.6% |
| Proqr Therapeutics | 1,720.2% |
| Spero Therapeutics | 1,660.9% |
| Ocular | 1,605.8% |
| Foamix Pharmaceuticals | 1,574.8% |
| Ab Science | 1,537.3% |
| Dicerna Pharmaceuticals | 1,382.6% |
| Gw Pharmaceuticals | 1,343.8% |
| Theravance Biopharma | 1,130.2% |
| Chimerix | 1,100.3% |
| Epizyme | 996.6% |
| Spark Therapeutics | 952.8% |
| Tetraphase Pharmaceuticals | 952.2% |
| Rigel Pharmaceuticals | 931.9% |
| R&D intensity | |
|---|---|
| Tanvex Biopharma | 821,643.6% |
| Obseva | 342,928.1% |
| Verona Pharma | 103,118.1% |
| Nantkwest | 88,322.1% |
| Endocyte | 82,756.3% |
| Regulus Therapeutics | 70,840.3% |
| TG Therapeutics | 67,287.9% |
| Bellicum Pharma | 35,393.7% |
| Intra-Cellular | 32,305.2% |
| Revance Therapeutics | 30,672.3% |
| Selecta Biosciences | 20,269.7% |
| Dynavax Technologies | 19,774% |
| Alder Biopharmaceuticals | 15,514.7% |
| Flexion Therapeutics | 14,431.3% |
| Clearside Biomedical | 14,118.3% |
| Vtv Therapeutics | 13,522% |
| Coherus Biosciences | 10,336.2% |
| Northwest Biotherapeutics | 9,874.7% |
| Ultragenyx Pharmaceutical | 8,749.8% |
| Isotechnika Pharma | 8,078.1% |
| Karyopharm Therapeutics | 6,583.7% |
| Ascendis Pharma | 6,463.3% |
| Idera Pharmaceuticals | 5,515.6% |
| Stemline Therapeutics | 5,493.5% |
| Cara Therapeutics | 5,246.2% |
| Tigenix | 5,031.6% |
| Syros Pharmaceuticals | 3,705.3% |
| Otonomy | 3,454.8% |
| Arcus Biosciences | 3,241.7% |
| Mesoblast | 2,877.5% |
| Unity Biotechnology | 2,704.3% |
| Immunomedics | 2,384.6% |
| Aclaris Therapeutics | 2,364.2% |
| Syndax Pharma | 2,286.6% |
| Dermira | 2,199.3% |
| Wave Life Sciences | 2,141.2% |
| Adverum Biotechnologies | 2,054.6% |
| Proqr Therapeutics | 1,720.2% |
| Spero Therapeutics | 1,660.9% |
| Ocular | 1,605.8% |
| Foamix Pharmaceuticals | 1,574.8% |
| Ab Science | 1,537.3% |
| Dicerna Pharmaceuticals | 1,382.6% |
| Gw Pharmaceuticals | 1,343.8% |
| Theravance Biopharma | 1,130.2% |
| Chimerix | 1,100.3% |
| Epizyme | 996.6% |
| Spark Therapeutics | 952.8% |
| Tetraphase Pharmaceuticals | 952.2% |
| Rigel Pharmaceuticals | 931.9% |
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Jan 7, 2019
This statistic represents the worlds's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2017/2018. In that year, Tanvex Biopharma from Taiwan had the highest R&D intensity of over 800,000 percent. The R&D intensity is calculated from a company's R&D spending divided by the company's sales.
- Show sources information
- Show publisher information
- Release date
- December 2018
- Region
- Worldwide
- Survey time period
- 2017 and 2018
- Supplementary notes
- * R&D intensity = R&D expenditures divided by sales.
Source
- Show sources information
- Show publisher information
- Release date
- December 2018
More information
- Region
- Worldwide
- Survey time period
- 2017 and 2018
- Supplementary notes
- * R&D intensity = R&D expenditures divided by sales.
Other statistics on the topic
Biotechnology industry
+Farming
Percentage of genetically modified crops in the U.S. by type 1997, 2018 & 2019
+Pharmaceutical Products & Market
Gross profit margin of select U.S. biotech and drugs companies Q2 2019
+Pharmaceutical Products & Market
Top global biotech companies based on market capitalization 2018
+Pharmaceutical Products & Market
Amgen's top product revenues 2016-2018
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Biotech industry
- 90 page/s
- English
- pptx
- Detailed references
Everything On "Biotech industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Other Reports & Dossiers
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Biotech industry"
- Global overview
The most important statistics
- Global top 10 companies based on biotech prescription drug revenue in 2018 and 2024 (in billion U.S. dollars)*Global top companies based on biotech prescription drug revenue in 2018 and 2024
- Top global biotechnology companies based on market capitalization as of 2018 (in billion U.S. dollars)Top global biotech companies based on market capitalization 2018
- Select top global biotechnology companies' R&D expenditure in 2018 (in million U.S. dollars)Top global biotech companies - R&D expenditure 2018
- Selected top biotechnology companies based on number of employees worldwide in 2017Top global biotech companies based on number of employees 2017
- Value of the NASDAQ biotech Index from 2010 to 2017NASDAQ biotech index closing values 2010-2017
- Change in pharmaceutical and biotech industry stock indices worldwide in 2018Change in global biotech-pharma industry stock indices 2018
- U.S. companies
The most important statistics
- Gilead Sciences' revenue from 2006 to 2018 (in million U.S. dollars)Gilead Sciences' revenue 2006-2018
- Top products of Gilead Sciences from 2016 to 2018, based on revenue (in million U.S. dollars)Gilead Sciences' top products based on revenue 2016-2018
- Total revenue of biotech company Amgen from 2004 to 2018 (in million U.S. dollars)Amgen's total revenue 2004-2018
- Revenues of selected Amgen's top products from 2016 to 2018 (in million U.S. dollars)Amgen's top product revenues 2016-2018
- Biogen's revenue and net income from 2007 to 2018 (in million U.S. dollars)Biogen's revenue and net income 2007-2018
- Biogen's top products from 2016 to 2018, based on revenue (in million U.S. dollars)Biogen's top products based on revenue 2016-2018
- Market capitalization compound annual growth rate of selected U.S. biotech companies between 2012 and 2016Market cap CAGR of biotech companies in the U.S. 2012-2016
- Pre-commercial U.S. biotech companies with large market capitalization as of March 2017 (in million U.S. dollars)*Pre-commercial biotech companies with large market caps in the U.S. 2017
- Research & development
The most important statistics
- World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2017/2018*Top 50 global pharmaceutical and biotech companies by R&D intensity in 2017/2018
- Average cost to bring a pharmaceutical asset to market among large cap biopharma companies between 2010 and 2018 (in billion U.S. dollars)Cost to bring large cap biopharmaceutical assets to market 2010-2018
- Average cost to bring a pharmaceutical asset to market among mid cap biopharma companies in 2010, 2016, 2017, and 2018 (in billion U.S. dollars)Cost to bring biopharmaceutical assets in mid cap companies to market 2010-2018
- Projected rate of return on biopharmaceutical research and development investments from 2010 to 2018Projected return on biopharma R&D investments U.S. 2010-2018
- Biotech alliances with big up-front payments in the U.S. and Europe in 2016 (in million U.S. dollars)Alliances in U.S. and Europe biotechnology industry with big up-front payments 2016
- Products
The most important statistics
- Total global biologics spending from 2002 and 2017 (in billion U.S. dollars)Global biologics spending 2002-2017
- Top selling biotech drugs worldwide in 2017 (in billion U.S. dollars)Top-selling biotech drugs based on revenue 2017
- Number of biopharma medicines in development in the U.S. as of April 2019, by therapeutic category*Pharmaceuticals: biopharma medicines in development in 2019, by category
- U.S. biopharmaceutical goods export volume from 2002 to 2017 (in billion U.S. dollars)U.S. biopharmaceutical export volume 2002-2017
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)Projection of top 2018 pharma and biotech launches by revenue 2022
- Total U.S. pharmaceutical and biotech revenues for products 5 years after launch from 2007 to 2017 (in billion U.S. dollars)Total U.S. pharma and biotech product sales 5 years after launch 2007-2017
- Funding/investment
The most important statistics
- Total biotechnology funding by the National Institutes for Health (NIH) from FY 2013 to FY 2020 (in million U.S. dollars)biotechnology funding by National Institutes for Health 2013-2020
- Bioscience venture capital investments in the U.S. between 2014 and 2017, by sector (in million U.S. dollars)U.S. bioscience venture capital investments by segment 2014-2017
- Biotech/pharmaceutical investments in the legal cannabis industry in the United States from 2015 to 2017 (in million U.S. dollars)*Legal cannabis industry investments on biotech in the U.S. 2015-2017
- Value of U.S. and European biotech initial public offerings (IPOs) in January-October 2017 (in million U.S. dollars)Value of U.S. and EU biotech IPOs, January-October 2017
- Value of the top U.S. biotech venture financings in 2017 (in million U.S. dollars)Amount of top U.S. biotech venture financings 2017
- Capital raised by regenerative medicine companies worldwide from 2016 to 2018 (in million U.S. dollars)*Capital raised by regenerative medicine companies worldwide 2016-2018
- Biotech in agriculture
The most important statistics
- Acreage of genetically modified crops worldwide from 2003 to 2018 (in million hectares)Acreage of genetically modified crops worldwide 2003-2018
- Acreage of genetically modified crops worldwide from 2015 to 2018, by leading country (in million hectares)*Acreage of genetically modified crops 2015-2018, by country
- Percentage of genetically modified crops in the U.S. in 1997, 2018 and 2019, by type (as percent of total acreage)Percentage of genetically modified crops in the U.S. by type 1997, 2018 & 2019
- Monsanto's net sales in the seeds and genomics segment from 2011 to 2017 by specialty (in million U.S. dollars)*Monsanto's seed and genomics segment net sales 2011-2017
- Sales of Syngenta AG worldwide from 2013 to 2018, by segment (in billion U.S. dollars)Syngenta AG's sales worldwide by segment 2013-2018
- Bayer CropScience's revenue from 2005 to 2018 (in million euros)Bayer CropScience's revenue 2005-2018
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Top pharma and biotech companies by sales growth in 2017-2018
- Leading UK pharmaceutical and biotechnology companies ranked by market value 2015
- Italy: number of statements about pharmaceuticals 2019, by brand
- Value of M&A transactions in biotechnology and pharmaceuticals sector 1985-2018
- Number of M&A transactions in biotechnology and pharmaceuticals sector 1985-2018
- Projected top pharmaceutical companies based on new sales 2018-2019
- Enterprise value of top companies in non-oncology rare disease therapeutics 2017
- Projection of top 10 global pharmaceutical companies by revenue 2019
- US adults who believe research results have an influence the US pharma industry
- Worldwide median pharmaceutical M&A value to revenue multiple 2011-2015
- U.S. venture investments in infectious disease companies 2006-2018
- Top global generic pharmaceutical companies, by enterprise value 2016
- Top global generic pharmaceutical companies 2015, by revenue
- U.S. generic pharmaceutical industry top acquisitions 2015
- Enterprise value of generic pharmaceutical companies with a U.S. presence 2016
- Research & development expenditure of biotechnology companies in Germany 2008-2017
- Forbes selected biotech companies in China & Hong Kong 2017, based on market value
- Astellas Pharma's operating profit FY 2008-2017
- Pharmaceutical company value among Chinese top 500 firms 2017
- Armani Group's global sales 2007-2009
Studies
- Pharmaceutical trends in Europe
- Biotechnology in Germany
- Pharmaceutical industry in Japan
- Pharmaceutical industry in China
- Biotechnology Industry in Europe
- Unleashing Pharma from the R&D Value Chain
- Indicatori Farmaceutici
- Pharmaceutical industry in India
- 2019 PhRMA Annual Membership Survey
- Pharmaceutical industry in Italy
- Vaccine industry in China
- California Life Sciences Industry Report 2019
- 2019 California Economic Impact Report - Data Book
- Generic Pharmaceutical Industry Yearbook 2016
- 2018 PhRMA Annual Membership Survey
Statistics on "Biotech industry"
- Global top companies based on biotech prescription drug revenue in 2018 and 2024
- Top global biotech companies based on market capitalization 2018
- Top global biotech companies - R&D expenditure 2018
- Top global biotech companies based on number of employees 2017
- NASDAQ biotech index closing values 2010-2017
- Change in global biotech-pharma industry stock indices 2018
- Gilead Sciences' revenue 2006-2018
- Gilead Sciences' top products based on revenue 2016-2018
- Amgen's total revenue 2004-2018
- Amgen's top product revenues 2016-2018
- Biogen's revenue and net income 2007-2018
- Biogen's top products based on revenue 2016-2018
- Market cap CAGR of biotech companies in the U.S. 2012-2016
- Pre-commercial biotech companies with large market caps in the U.S. 2017
- Gross profit margin of select U.S. biotech and drugs companies Q2 2019
- Expected top life science startups in the U.S. 2019
- Top 50 global pharmaceutical and biotech companies by R&D intensity in 2017/2018
- Cost to bring large cap biopharmaceutical assets to market 2010-2018
- Cost to bring biopharmaceutical assets in mid cap companies to market 2010-2018
- Projected return on biopharma R&D investments U.S. 2010-2018
- Alliances in U.S. and Europe biotechnology industry with big up-front payments 2016
- Global biologics spending 2002-2017
- Top-selling biotech drugs based on revenue 2017
- Pharmaceuticals: biopharma medicines in development in 2019, by category
- U.S. biopharmaceutical export volume 2002-2017
- Projection of top 2018 pharma and biotech launches by revenue 2022
- Total U.S. pharma and biotech product sales 5 years after launch 2007-2017
- biotechnology funding by National Institutes for Health 2013-2020
- U.S. bioscience venture capital investments by segment 2014-2017
- Legal cannabis industry investments on biotech in the U.S. 2015-2017
- Value of U.S. and EU biotech IPOs, January-October 2017
- Amount of top U.S. biotech venture financings 2017
- Capital raised by regenerative medicine companies worldwide 2016-2018
- Acreage of genetically modified crops worldwide 2003-2018
- Acreage of genetically modified crops 2015-2018, by country
- Percentage of genetically modified crops in the U.S. by type 1997, 2018 & 2019
- Monsanto's seed and genomics segment net sales 2011-2017
- Syngenta AG's sales worldwide by segment 2013-2018
- Bayer CropScience's revenue 2005-2018
- Top pharma and biotech companies by sales growth in 2017-2018
- Leading UK pharmaceutical and biotechnology companies ranked by market value 2015
- Italy: number of statements about pharmaceuticals 2019, by brand
- Value of M&A transactions in biotechnology and pharmaceuticals sector 1985-2018
- Number of M&A transactions in biotechnology and pharmaceuticals sector 1985-2018
- Projected top pharmaceutical companies based on new sales 2018-2019
- Enterprise value of top companies in non-oncology rare disease therapeutics 2017
- Projection of top 10 global pharmaceutical companies by revenue 2019
- US adults who believe research results have an influence the US pharma industry
- Worldwide median pharmaceutical M&A value to revenue multiple 2011-2015
- U.S. venture investments in infectious disease companies 2006-2018
- Top global generic pharmaceutical companies, by enterprise value 2016
- Top global generic pharmaceutical companies 2015, by revenue
- U.S. generic pharmaceutical industry top acquisitions 2015
- Enterprise value of generic pharmaceutical companies with a U.S. presence 2016
- Research & development expenditure of biotechnology companies in Germany 2008-2017
- Forbes selected biotech companies in China & Hong Kong 2017, based on market value
- Astellas Pharma's operating profit FY 2008-2017
- Pharmaceutical company value among Chinese top 500 firms 2017
- Armani Group's global sales 2007-2009
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month*
| |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Yes, let me download!
...and make my research life easier.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.